N.D. Cent. Code § 23-23.1-01

Current through 2023 Legislative Sessions
Section 23-23.1-01 - Use of laetrile authorized

No hospital or health facility may interfere with the physician-patient relationship by restricting or forbidding the use of amygdalin when prescribed or administered by a licensed physician and requested by a patient unless the substance as prescribed or administered by the physician is found to be harmful by the North Dakota board of medicine in a hearing conducted pursuant to chapter 28-32.

N.D.C.C. § 23-23.1-01

Amended by S.L. 2015, ch. 297 (HB 1153),§ 5, eff. 8/1/2015.